Clinical Trial

BCD to Measure the ED95 of Remimazolam-Assisted Sedation in Arteriovenous Fistula Creation Surgery

Study acronym: BCD
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study intends to measure the ED95 of remimazolam-assisted sedation in arteriovenous fistula creation by BCD.
Trial Details
NCT Number NCT06998732
Lead Sponsor Gang Chen
Conditions Uremia
Enrollment 40 participants
Start Date 2025-06-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-31